Empowering People to Take Control of Health
Dexcom Corporation (NASDAQ DXCM) has been a pioneer in glucose sensing for more than 25 years. Since 1999, we have developed innovative technologies that transformed how people manage diabetes. Our products are part of people’s daily lives, empowering them to live confidently and feel more in control, free to pursue their dreams.
Headquartered in San Diego, California, with operations around the world, Dexcom leads by listening to the needs of users, caregivers, and providers, to simplify and improve glucose management.
For more than 35 years, Medtronic Diabetes has continued to drive innovation, including new insulin delivery solutions. We are committed to innovating further. With a renewed focus on creating products that are easy to use, we hope our future technologies will enable people to focus more on life, and not diabetes. Medtronic MiniMed, inc. is a wholly owned subsidiary of Medtronic, Inc.
Connect with us!
Facebook @ www.facebook.com/medtronicdiabetes
Instagram @ www.instagram.com/medtronicdiabetes/
Twitter @ https://twitter.com/MDT_Diabetes
YouTube @ https://www.youtube.com/c/MedtronicDiabetesUS
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology and has a vision to create a world without limits for people with diabetes and related conditions. More than 20 million people and their caregivers around the world count on LifeScan’s OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch improve the quality of life for people with diabetes with products and digital platforms defined by simplicity, accuracy, and trust.